基础医学与临床 ›› 2016, Vol. 36 ›› Issue (2): 262-266.

• 短篇综述 • 上一篇    下一篇

CPT1基因在肿瘤中的研究进展

沈天允,史志周   

  1. 云南省昆明市昆明理工大学
  • 收稿日期:2015-07-13 修回日期:2015-09-29 出版日期:2016-02-05 发布日期:2016-01-21
  • 通讯作者: 史志周 E-mail:zhizhoushi@126.com
  • 基金资助:
    氯离子通道蛋白ANO1在食管鳞癌细胞增殖中的作用机制研究;CPTIA在食管鳞癌上皮—间质转化中的作用及其分子机制研究;CPT1A基因在食管癌转移中的作用研究

Research progress of CPT1 gene in tumor

1,   

  • Received:2015-07-13 Revised:2015-09-29 Online:2016-02-05 Published:2016-01-21

摘要: 肉碱棕榈酰转移酶1(CPT1)是肝脏组织细胞中长链脂肪酸β-氧化的关键调节酶和限速酶。其亚型CPT1A和CPT1C能够促进肿瘤的生长。CPT1A在胶质母细胞瘤、淋巴瘤、食管癌和乳腺癌等多种恶性肿瘤中扩增且高表达,抑制CPT1A活性和表达的药物具有明显的抗肿瘤作用。因此CPT1在肿瘤癌变中具有重要促进作用,可能成为肿瘤诊断的分子标志物和抗肿瘤治疗的新靶点。

关键词: CPT1, β-氧化, 恶性肿瘤, 肿瘤癌变

Abstract: Carnitine palmitoyltransferase 1 (CPT1) is the key and rate-limiting enzyme of long chain fatty acids β-oxidation in liver cells. CPT1A and CPT1C are subtypes of CPT1 which can promote tumor growth. CPT1A was overexpressed and amplificated in glioblastoma, lymphoma, esophageal cancer and breast cancer. The drugs which could inhibit the activity or expression of CPT1A had anti-tumor effects. Therefore, CPT1 has roles in promoting the tumorigenesis, and it may develop into an molecular biomarker and a new target for cancer therapy.

Key words: CPT1, β-oxidation, malignant tumor, tumorigenesis

中图分类号: